[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[H.R. 4931 Introduced in House (IH)]

<DOC>






114th CONGRESS
  2d Session
                                H. R. 4931

 To direct the Attorney General to establish a national pharmaceutical 
   stewardship program to facilitate the collection and disposal of 
                       prescription medications.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                             April 13, 2016

Ms. Slaughter introduced the following bill; which was referred to the 
                    Committee on Energy and Commerce

_______________________________________________________________________

                                 A BILL


 
 To direct the Attorney General to establish a national pharmaceutical 
   stewardship program to facilitate the collection and disposal of 
                       prescription medications.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Pharmaceutical Stewardship Act of 
2016''.

SEC. 2. NATIONAL PHARMACEUTICAL STEWARDSHIP PROGRAM.

    (a) In General.--The Attorney General, acting through the 
Administrator of the Drug Enforcement Administration, shall establish 
and implement a national pharmaceutical stewardship program to 
facilitate the collection and disposal of prescription medications at 
the locations at which such prescription medications are dispensed.
    (b) Annual Fees.--
            (1) In general.--The Attorney General may assess, collect, 
        and use, without further appropriation, annual fees from 
        producers of prescription medications to pay the administrative 
        costs of carrying out this section.
            (2) Amount of fees.--The Attorney General shall allocate 
        the amount of fees under this subsection among the producers of 
        prescription medications in a manner that provides for a fair 
        and reasonable allocation of the costs of carrying out this 
        section across such producers.
                                 <all>